James Woodruff Lillie insider trades
Open-market stock purchases and sales by James Woodruff Lillie, Chief Scientific Officer at MapLight Therapeutics, Inc, from SEC Form 4 filings since Mar 6, 2018.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 17, 2026 | MPLT MapLight Therapeutics, Inc | Bought (not open market) | — |
| Aug 17, 2026 | MPLT MapLight Therapeutics, Inc | Bought (not open market) | — |
| Aug 3, 2026 | MPLT MapLight Therapeutics, Inc | Sold | $277K |
| Jul 17, 2026 | MPLT MapLight Therapeutics, Inc | Sold | $78.7K |
| Jul 16, 2026 | MPLT MapLight Therapeutics, Inc | Sold | $183K |
| Jul 16, 2026 | MPLT MapLight Therapeutics, Inc | Sold | $131K |
| Jul 16, 2026 | MPLT MapLight Therapeutics, Inc | Sold | $456 |
| Jul 15, 2026 | MPLT MapLight Therapeutics, Inc | Sold | $80.6K |
| Jul 15, 2026 | MPLT MapLight Therapeutics, Inc | Sold | $199K |
| Jul 15, 2026 | MPLT MapLight Therapeutics, Inc | Sold | $450 |
| May 7, 2026 | MPLT MapLight Therapeutics, Inc | Sold | $20.4K |
| May 6, 2026 | MPLT MapLight Therapeutics, Inc | Sold | $235K |
| May 6, 2026 | MPLT MapLight Therapeutics, Inc | Sold | $478K |
| May 5, 2026 | MPLT MapLight Therapeutics, Inc | Sold | $285K |
| May 5, 2026 | MPLT MapLight Therapeutics, Inc | Sold | $27.9K |
| May 4, 2026 | MPLT MapLight Therapeutics, Inc | Sold | $254K |
| May 4, 2026 | MPLT MapLight Therapeutics, Inc | Sold | $157K |
| May 4, 2026 | MPLT MapLight Therapeutics, Inc | Sold | $9.5K |
| May 4, 2026 | MPLT MapLight Therapeutics, Inc | Sold | $21.2K |
| Apr 16, 2026 | MPLT MapLight Therapeutics, Inc | Sold | $18.5K |
| Apr 16, 2026 | MPLT MapLight Therapeutics, Inc | Sold | $57.6K |
| Apr 15, 2026 | MPLT MapLight Therapeutics, Inc | Sold | $46.4K |
| Feb 5, 2026 | MPLT MapLight Therapeutics, Inc | Bought (not open market) | — |
| Feb 5, 2026 | MPLT MapLight Therapeutics, Inc | Bought (not open market) | — |
| Jan 27, 2026 | MPLT MapLight Therapeutics, Inc | Sold (not open market) | $810K |
Get free alerts when James Woodruff Lillie files a new trade →